{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:13:00Z","timestamp":1747195980197,"version":"3.40.5"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>There is still a lack of research in Vietnam on the autoantibody profile of dermatomyositis (DM) and its association with clinical and subclinical characteristics. Therefore, we conducted this study to investigate clinical and subclinical correlations with autoantibodies in DM patients. 72 DM patients at Vietnam National Hospital of Dermatology and Venereology (NHDV) from March 2019 to September 2021 were included in this cross-sectional study. Clinical manifestations and laboratory test results of the patients were obtained at the time of visit. Of these, 63 patients were tested for the presence of autoantibodies using an Immunoblot assay. Our findings show that the average age of patients was 41.7 years. The female-male ratio was 1.7:1. The most common skin and muscle manifestations were myalgia (79.2%), heliotrope rash (62.5%), shawl sign (61.1%), Gottron\u2019s sign (59.7%), muscle weakness (59.7%), Gottron\u2019s papule (52.8%), periungual telangiectasia (41.7%), V-sign (38.9%), poikiloderma (26.4%), periungual fissures (20.8%), Raynaud\u2019s phenomenon (15.3%). Among the 63 patients tested for autoantibodies, myositis-specific antibodies (MSAs) were found in 71.4% of the serum samples, and myositis-associated antibodies (MAAs) in 36.5%. Anti-TIF1\u03b3 antibody accounted for the highest percentage (28.6%), followed by anti-Ro52 (22.2%), anti-synthetase (17.5%), anti-Mi-2 and anti-MDA5 (both 14.3%). Anti-synthetase antibodies (ARS-Abs) showed a significant association with arthralgia, fever, and Raynaud\u2019s phenomenon, while anti-TIF1\u03b3 antibodies showed a strong association with V-sign and poikiloderma (p&lt;0.05). Clinical features in dermatomyositis are heterogeneous. Our study results show some associations between clinical features and autoantibodies in patients with DM. The analysis of DM-related autoantibodies is clinically useful, will be essential for the approaches to diagnosis, and management of DM patients.<\/jats:p>","DOI":"10.1371\/journal.pgph.0000979","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T18:29:25Z","timestamp":1673548165000},"page":"e0000979","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients"],"prefix":"10.1371","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-1483","authenticated-orcid":true,"given":"My Huyen","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-9567","authenticated-orcid":true,"given":"Hoa Thi","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3337-2981","authenticated-orcid":true,"given":"Thu Thi Hoai","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-609X","authenticated-orcid":true,"given":"Phuong Thi","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-0209","authenticated-orcid":true,"given":"Minh Nguyet","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-9905","authenticated-orcid":true,"given":"Doanh Huu","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"issue":"3","key":"pgph.0000979.ref001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.31138\/mjr.30.3.155","article-title":"Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing","volume":"30","author":"M Mende","year":"2019","journal-title":"Mediterr J Rheumatol"},{"key":"pgph.0000979.ref002","doi-asserted-by":"crossref","first-page":"9141420","DOI":"10.1155\/2019\/9141420","article-title":"Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome","volume":"2019","author":"C Cassius","year":"2019","journal-title":"J Immunol Res"},{"issue":"4","key":"pgph.0000979.ref003","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"K Tanimoto","year":"1995","journal-title":"J Rheumatol"},{"issue":"4","key":"pgph.0000979.ref004","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Y Hamaguchi","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"pgph.0000979.ref005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"M Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"pgph.0000979.ref006","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease","volume":"23","author":"S Sato","year":"2013","journal-title":"Mod Rheumatol"},{"key":"pgph.0000979.ref007","doi-asserted-by":"crossref","first-page":"415272","DOI":"10.5402\/2012\/415272","article-title":"Anti-ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma","volume":"2012","author":"JP Ferreira","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"2","key":"pgph.0000979.ref008","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/key313","article-title":"Clinical phenotype, autoantibody profile and HLA-DR-type in Vietnamese patients with idiopathic inflammatory myopathies","volume":"58","author":"T Nguyen Thi Phuong","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"issue":"10","key":"pgph.0000979.ref009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1365-4362.2002.01482.x","article-title":"Dermatomyositis: cutaneous manifestations of its variants","volume":"41","author":"LA Dourmishev","year":"2002","journal-title":"Int J Dermatol"},{"issue":"5","key":"pgph.0000979.ref010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1756-185X.12107","article-title":"Clinical features and disease course of patients with juvenile dermatomyositis","volume":"16","author":"PJ Gowdie","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"pgph.0000979.ref011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archderm.1959.01560180043013","article-title":"Calcinosis in dermatomyositis; observations on course of disease in children and adults","volume":"79","author":"SA Muller","year":"1959","journal-title":"AMA Arch Dermatol"},{"issue":"7","key":"pgph.0000979.ref012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"A Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"10","key":"pgph.0000979.ref013","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archderm.1994.01690100078013","article-title":"Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound","volume":"130","author":"MR Stonecipher","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"pgph.0000979.ref014","first-page":"336","article-title":"Diagnostic and differential diagnostic value of troponins","volume":"91","author":"W Prellwitz","year":"1996","journal-title":"Med Klin Munich Ger"},{"issue":"4","key":"pgph.0000979.ref015","doi-asserted-by":"crossref","DOI":"10.23937\/2469-5726\/1510025","article-title":"In the Idiopathic Inflammatory Myopathies, How Significant is Creatine Kinase Levels in Diagnosis and Prognosis? A Case Study and Review of the Literature","volume":"1","author":"TC Sizemore","year":"2015","journal-title":"J Rheum Dis Treat"},{"issue":"10","key":"pgph.0000979.ref016","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","article-title":"Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients","volume":"38","author":"N Ikeda","year":"2011","journal-title":"J Dermatol"},{"issue":"10","key":"pgph.0000979.ref017","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/1346-8138.15049","article-title":"Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies","volume":"46","author":"H Fukamatsu","year":"2019","journal-title":"J Dermatol"},{"issue":"11","key":"pgph.0000979.ref018","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"IN Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"pgph.0000979.ref019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","article-title":"Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy","volume":"46","author":"K Kaji","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"pgph.0000979.ref020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"H Gunawardena","year":"2008","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"pgph.0000979.ref021","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/art.1780390521","article-title":"Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain","volume":"39","author":"R Mierau","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"pgph.0000979.ref022","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","article-title":"Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis","volume":"40","author":"K Komura","year":"2005","journal-title":"J Dermatol Sci"},{"issue":"5","key":"pgph.0000979.ref023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","article-title":"Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies","volume":"20","author":"PW Wolstencroft","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"20","key":"pgph.0000979.ref024","doi-asserted-by":"crossref","first-page":"e15578","DOI":"10.1097\/MD.0000000000015578","article-title":"Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis","volume":"98","author":"J Temmoku","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"pgph.0000979.ref025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"P Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"12","key":"pgph.0000979.ref026","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/rheumatology\/ker267","article-title":"Idiopathic interstitial lung disease with anti-SSA antibody","volume":"50","author":"JF Boitiaux","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"pgph.0000979.ref027","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.chest.2016.04.007","article-title":"Management of Myositis-Related Interstitial Lung Disease","volume":"150","author":"J Morisset","year":"2016","journal-title":"Chest"},{"issue":"7","key":"pgph.0000979.ref028","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease","volume":"60","author":"S Sato","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0000979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T22:35:01Z","timestamp":1679351701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0000979"}},"subtitle":[],"editor":[{"given":"Collins Otieno","family":"Asweto","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0000979","relation":{},"ISSN":["2767-3375"],"issn-type":[{"type":"electronic","value":"2767-3375"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}